Zoonoses and fertility control in wildlife - Requirements for vaccines

Reproduction, Fertility and Development

Volumn 9, Issue 1, 1997, Pages 149-155

  Stohr K ^a   Meslin, F X ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; CONTRACEPTIVE VACCINE; RABIES VACCINE;

BIRTH CONTROL; CONFERENCE PAPER; NONHUMAN; ORAL DRUG ADMINISTRATION; PEST CONTROL; VIRUS RECOMBINANT; WILDLIFE; ZOONOSIS;

ANIMALS; ANIMALS, WILD; CONTRACEPTION, IMMUNOLOGIC; RABIES; RABIES VACCINES; VACCINES; ZOONOSES;

ANIMALIA;

EID: 0030940830     PISSN: 10313613     EISSN: None     Source Type: Journal    
DOI: 10.1071/R96055     Document Type: Conference Paper

References (59)

1. Artois, M., Charlton, K. M., Tolson, N. D., Casey, G. A., Knowles, M. K., and Campbell, J. B. (1990). Vaccinia recombinant virus expressing the rabies virus glycoprotein: safety and efficacy trials in Canadian wildlife. Can. J. Vet. Res. 54, 504-7.
2. Aubert, M. (1994). Control of rabies in foxes - what are the appropriate measures? Vet. Rec. 134, 55-9.
3. Benmansour, A., Leblois, H., Coulon, P., Tuffereau, C., Gaudin, Y., Flamand, A., and Lafay, F. (1991). Antigenicity of rabies virus glycoprotein. J. Virol. 65, 4198-203.
4. Bostock, C. J. (1995). Live virus vaccines for use in animals. Dev. Biol Stand. 84, 41-8.
5. Brochier, B., Kieny, M. P., Costy, F., Coppens, P., Bauduin, B., Lecocq, J. P., Languet, B., Chappuis, G., Desmettre, P., and Afiademanyo, K. (1991). Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine [see comments]. Nature (Lond.) 354, 520-2.
6. Brochier, B., Costy, F., Marchal, A., Peharpre, D., Mosselmans, F., Beyer, R., Bauduin, B., and Pastoret, P. P. (1994a). Epidemiosurveillance of rabies in Belgium - the situation in 1993. Ann. Med. Vet. 138, 199-204.
7. Brochier, B., Boulanger, D., Costy, F., and Pastoret, P. P. (1994b). Towards rabies elimination in Belgium by fox vaccination using a vaccinia-rabies glycoprotein recombinant virus. Vaccine 12, 1368-71.
8. Coulon, P., Lafay, F., Leblois, H., Tuffereau, C., Artois, M., Blancou, J., Benmansour, A., and Flamand, A. (1992). The SAG: a new attenuated oral rabies vaccine. In 'Wildlife Rabies Control'. (Eds K. Bögel, F. X. Meslin and M. Kaplan.) pp. 105-11. (Wells Medical: Kent, UK.)
9. Desmettre, P., Languet, B., Chappuis, G., Brochier, B., Thomas, I., Lecocq, J. P., Kieny, M. P., Blancou, J., Aubert, M., Artois, M., and Pastoret, P. P. (1990). Use of vaccinia rabies recombinant for oral vaccination of wildlife. Vet. Microbiol. 23, 227-36.
10. Flamand, A., Coulon, P., Lafay, F., and Tuffereau, C. (1993). Avirulent mutants of rabies virus and their use as live vaccine. Trends Microbiol. 1, 317-20.
11. Griffin, D. (1990). Strategy for vaccine development. In 'Gamete Interaction. Prospects for Immunocontraception'. (Eds N. J. Alexander, D. Griffin, J. M. Spieler and G. M. H. Waites.) pp. 503-24. (Wiley-Liss: New York.)
12. Guittre, C., Artois, M., and Flamand, A. (1992). Use of an avirulent mutant of rabies virus for the oral vaccination of wild animals: innocuity in several non-target species. Ann. Med. Vet. 136, 329-32.
13. Häflinger, U., Bichsel, P., Wandeler, A., and Steck, F. (1982). Oral immunization of foxes against rabies - stabilization and use of bait for the virus. Zentralbl. Vet. Med. B 29, 604-18.
14. Hanlon, C. A. (1994). A vaccina recombinant virus: comparative evaluations among free ranging, immunocompetent and immunodeficient hosts. Ph.D. Thesis. University of Pennsylvania, USA.
15. Hillermann, M. R. (1995). Viral vaccines in historical perspective. Dev. Biol. Stand. 84, 107-16.
16. Kappeler, A. (1992). Oral immunization of foxes against rabies in Switzerland. Ph.D. Thesis. University of Bern, Switzerland.
17. Kieny, M. P., Lathe, R., Drillien, R., Spehner, D., Skory, S., Schmitt, D., Wiktor, T., Koprowski, H., and Lecocq, J. P. (1984). Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature (Lond.) 312, 163-6.
18. Kintscher, M., Bernhard, J., and Lemke, I. (1990). Investigations of the safety, innocuity and efficacy of the SAD/Potsdam 5/88 strain for rabies vaccination. Mh. Vet. Med. 45, 81-4.
19. Lafay, F., Benejean, J., Tuffereau, C., Flamand, A., and Coulon, P. (1994). Vaccination against rabies - construction and characterization of SAG-2, a double avirulent derivative of SAD(Bern). Vaccine 12, 317-20.
20. Le Blois, H., Tuffereau, C., Blancou, J., Artois, M., Aubert, A., and Flamand, A. (1990). Oral immunization of foxes with avirulent rabies virus mutants. Vet. Microbiol. 23, 259-66.
21. Lindberg, A. A. (1995). The history of live bacterial vaccines. Dev. Biol. Stand. 84, 211-20.
22. Matouch, O., and Jaros, J. (1992). Control of fox rabies by oral immunization in the Czech Republic. Rab. Bull. Eur. 16(2), 12-13.
23. Pastoret, P. P., and Brochier, B. (1992). Development of a recombinant vaccinia-rabies vaccine for oral vaccination of foxes against rabies. Dev. Biol. Stand. 79, 105-11.
24. Prehaud, C., Coulon, P., Lafay, F., Thiers, C., and Flamand, A. (1988). Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence. J. Virol. 62, 1-7.
25. Rupprecht, C. E., Hanlon, C. A., Cummins, L. B., and Koprowski, H. (1992). Primate responses to a vaccinia-rabies glycoprotein recombinant virus vaccine. Vaccine 10, 368-74.
26. Rupprecht, C. E., Hanlon, C. A., Niezgoda, M., Buchanan, J. R., Diehl, D., and Koprowski, H. (1993). Recombinant rabies vaccines - efficacy assessment in free-ranging animals. Onderstepoort J. Vet. Res. 60, 463-8.
27. Schneider, L. G., and Cox, J. H. (1983). A field trial for the oral immunization of foxes against rabies in the Federal Republic of Germany. I. Safety, efficacy and stability of the SAD B19 vaccine. Tierärztl. Umsch. 38, 315-24.
28. Schneider, L. G., Wachendörfer, G., Schmittdiel, E., and Cox, J. H. (1983). A field trial for the oral immunization of foxes against rabies in the Federal Republic of Germany. II. Planning, implementation and evaluation of the field trial. Tierärztl. Umsch. 38, 476-80.
29. Schneider, L. G., Cox, J. H., Müller, W. W., and Hohnsbeen, K. P. (1988). Current oral rabies vaccination in Europe: an interim balance. Rev. Inf. Dis. 10 (Suppl. 4), 654-9.
30. Schumacher, C. L., Coulon, P., Lafay, F., Benejean, J., Aubert, M. F. A., Barrat, J., Aubert, A., and Flamand, A. (1993). SAG-2 oral rabies vaccine. Onderstepoort J. Vet. Res. 60, 459-62.
31. Seif, I., Coulon, P., Rollin, P. E., and Flamand, A. (1985). Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J. Virol. 53, 926-34.
32. Sinnecker, H., Apitzsch, L., Berndt, D., Schrader, C., Gogolin, J., and Egert, J. (1990). Development of SAD Potsdam 5/88 rabies live vaccine virus for oral vaccination of foxes, and its characterisation by a mouse model. Mh. Vet. Med. 45, 77-8.
33. Steck, F., Wandeler, A., Bichsel, P., Capt, S., and Schneider, L. G. (1982). Oral immunization of foxes against rabies: a field study. Zentralbl. Vet. Med. B 29, 372-96.
34. Stöhr, K., and Meslin, F. X. (1996). Progress and setbacks in oral immunization of foxes against rabies in Europe. Vet. Rec. 139, 32-5.
35. Stöhr, K., Karge, E., Gädt, H., Kokles, R., Ehrentraut, W., Witt, W., and Fink, H.-G. (1990). Oral immunization of free-living foxes against rabies. Preparation and implementation of first field trials conducted in East Germany. Mh. Vet. Med. 45, 782-6.
36. Stöhr, K., Stöhr, P., and Müller, T. (1994). Results and experiences of oral vaccination of foxes against rabies in Eastern Germany. Tierärztl. Umsch. 49, 203-11.
37. Svrcek, S., Durove, A., Sokol, J., Süliova, J., Ondrejka, R., Zavadova, J., Benisek, Z., Lani, D., Selimov, M., Vrtiak, J., Feketeova, D., Zurek, A., Lovas, B., Hojsik, J., Borsukova, O., Kuninec, J., and Juska, M. (1994). Immunoprophylaxis of rabies in wild carnivores. Slov. Vet. Cas. 2, 50-5.
38. Tolson, N. D., Charlton, K. M., Stewart, R. B., Casey, G. A., Webster, W. A., MacKenzie, K., Campbell, J. B., and Lawson, K. F. (1990). Mutants of rabies viruses in skunks: immune response and pathogenicity. Can. J. Vet. Res. 54, 178-83.
39. Tuffereau, C., Leblois, H., Benejean, J., Coulon, P., Lafay, F., and Flamand, A. (1989). Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice. Virology 172, 206-12.
40. Tyndale-Biscoe, C. H. (1994). Virus-vectored immunocontraception of feral mammals. In 'Immunological Control of Fertility: from Gametes to Gonads'. Reprod. Fertil. Dev. 6, 281-7.
41. Wandeler, A. I., Bauder, W., Prochaska, S., and Steck, F. (1982) Small mammal studies in a SAD baiting area. Comp. Immunol. Microbiol. Infect. 5, 173-6.
42. Wandeler, A., Capt, S., Kappeler, A., and Hauser, R. (1988). Oral immunization of wildlife against rabies: concepts and first field experiments. Rev. Inf. Dis. 10, 649-53.
43. Wiktor, T. J., Macfarlan, R. I., Reagan, K. J., Dietzschold, B., Curtis, P. J., Wunner, W. H., Kieny, M. P., Lathe, R., Lecocq, J. P., and Mackett, M. (1984). Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc. Natl Acad. Sci. USA 81, 7194-8.
44. Woolcock, P. R., and Crighton, G. W. (1979). Duck virus hepatitis: serial passsage of attenuated virus in ducklings. Vet. Rec. 105, 30-2.
45. World Health Organization. (1980). 'Report of a WHO Consultation on Rabies Prevention and Control, Lyon, France, March 1980'. (World Health Organization: Geneva.) (WHO/Rabies/80·188.)
46. World Health Organization. (1982). 'Report on a WHO Consultation on Oral and Enteric Mass Immunization of Wildlife, Geneva, September 1982'. (World Health Organization: Geneva.) (WHO/Rab.Res./82·16.)
47. World Health Organization. (1987). 'Report of WHO Workshop on Oral Immunization of Wildlife against Rabies in Europe (INTORAL), Tübingen, FRG, October 1986'. (World Health Organization: Geneva.) (WHO/Rab.Res./87·23.)
48. World Health Organization. (1988). 'Report of the Second International IMVI-Essen/WHO Symposium on New Developments in Rabies Control, Essen FRG, July 1988'. (World Health Organization: Geneva.) (WHO/Rab.Res./88·31.)
49. World Health Organization. (1989). 'Report of WHO Consultation on Requirements and Criteria for Field Trials on Oral Rabies Vaccination of Dogs and Wild Carnivores. Geneva. March 1989'. (World Health Organization: Geneva.) (WHO/Rab.Res./89·32.)
50. World Health Organization. (1990a). 'Report of the WHO Seminar on Wildlife Rabies Control, Geneva. July 1990'. (World Health Organization: Geneva.) (WHO/CDS/VPH/90·93.)
51. World Health Organization. (1990b). 'Guidelines for Dog Population Management'. (World Health Organization and World Society for the Protection of Animals: Geneva.) (WHO/ZOON/90·165.)
52. World Health Organization. (1991). 'Report of the Second Consultation on Oral Immunization of Dogs against Rabies, Geneva, July 1990'. (World Health Organization: Geneva.) (WHO/Rab.Res./91·37.)
53. World Health Organization. (1992a). 'Report of the Third Consultation on Oral Immunization of Dogs against Rabies, Geneva, July 1992'. (World Health Organization: Geneva.) (WHO/Rab.Res./92·38.)
54. World Health Organization. (1992b). 'WHO Expert Committee on Rabies, Eighth Report'. (World Health Organization: Geneva.)
55. World Health Organization. (1993a). 'WHO Informal Consultation on Reproductive Control of Carnivores. Geneva, June 1993'. (World Health Organization: Geneva.) (WHO/CDS/VPH/93·124.)
56. World Health Organization. (1993b). 'Report of the Fourth Consultation on Oral Immunization of Dogs against Rabies, Geneva, June 1993'. (World Health Organization: Geneva.) (WHO/Rab.Res./93·42.)
57. World Health Organization. (1994). 'Report of the Fifth Consultation on Oral Immunization of Dogs against Rabies, Geneva, June 1994'. (World Health Organization: Geneva.) (WHO/Rab.Res./94·45.)
58. World Health Organization. (1995a). 'Proceedings of the Fourth Concertation Meeting on Rabies Control in Europe, Piestany, Slovak Republic, October 1993'. (World Health Organization: Geneva.)
59. World Health Organization. (1995b). 'Report of the Global Consultation of Goverment-designated Experts on International Technical Guidelines for Safety in Biotechnology, Cairo. December 1995'. (World Health Organization: Geneva.) (UNEP/Global Consultation/Biosafety/4.)